|
PARD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.239500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.801240E-01 |
| Normal-vs-Stage2 |
4.539000E-01 |
| Normal-vs-Stage3 |
1.013760E-01 |
| Normal-vs-Stage4 |
4.775400E-01 |
| Stage1-vs-Stage2 |
9.630200E-01 |
| Stage1-vs-Stage3 |
2.747000E-01 |
| Stage1-vs-Stage4 |
9.107000E-01 |
| Stage2-vs-Stage3 |
4.087600E-01 |
| Stage2-vs-Stage4 |
9.435400E-01 |
| Stage3-vs-Stage4 |
5.540200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.222300E-02 |
| Normal-vs-AfricanAmerican |
7.733400E-01 |
| Normal-vs-Asian |
3.998600E-01 |
| Caucasian-vs-AfricanAmerican |
9.469500E-02 |
| Caucasian-vs-Asian |
8.115000E-01 |
| AfricanAmerican-vs-Asian |
3.393800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.284600E-01 |
| Normal-vs-Female |
1.695310E-03 |
| Male-vs-Female |
1.311720E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.776400E-01 |
| Normal-vs-Extreme_Weight |
6.987200E-01 |
| Normal-vs-Obese |
2.960000E-02 |
| Normal-vs-Extreme_Obese |
8.338800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.741600E-01 |
| Normal_Weight-vs-Obese |
4.666300E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.729600E-01 |
| Extreme_Weight-vs-Obese |
6.795800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.221800E-01 |
| Obese-vs-Extreme_Obese |
2.480400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.488400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.088300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.506000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.173200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.371600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.711660E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.690280E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.201000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.521760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.913030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.102240E-01 |
| Normal-VS-Type2 PRCC |
1.865050E-01 |
| Normal-VS-KIRP CIMP |
2.705900E-02 |
| Normal-VS-Unclassified PRCC |
8.144300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.351200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.338700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.319800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.723700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.128200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.079500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.502600E-01 |
| Normal-vs-N1 |
3.796500E-02 |
| Normal-vs-N2 |
3.059800E-01 |
| N0-vs-N1 |
3.688400E-02 |
| N0-vs-N2 |
2.009200E-01 |
| N1-vs-N2 |
7.410200E-01 |
|
|
